Immediate Impact

3 from Science/Nature 59 standout
Sub-graph 1 of 24

Citing Papers

Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
2025 Standout
Targeting protein–ligand neosurfaces with a generalizable deep learning tool
2025 StandoutNature
2 intermediate papers

Works of Pierre Feugier being referenced

Salvage outcomes in patients with first relapse after fludarabine, cyclophosphamide, and rituximab for chronic lymphocytic leukemia: The French intergroup experience
2015
Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients
2001
and 2 more

Author Peers

Author Last Decade Papers Cites
Pierre Feugier 760 702 408 68 1.0k
Inhye E. Ahn 793 607 389 68 1.1k
Christian H. Geisler 762 707 436 49 1.0k
Loïc Ysebaert 892 762 436 57 1.3k
M.J. Mackie 630 441 331 39 1.1k
Anna‐Maria Fink 858 800 358 57 1.0k
Piers Patten 838 579 483 69 1.1k
Yair Herishanu 418 441 403 87 1.1k
David Hakimian 636 435 300 46 1.0k
Kerry A. Rogers 1088 857 396 121 1.3k
Robert Foà 885 616 748 57 1.4k

All Works

Loading papers...

Rankless by CCL
2026